Insel Gruppe AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.inselgruppe.ch
Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)
Not Applicable
Completed
- Conditions
- Difficult Intubation
- Interventions
- Device: Airtraq, blade without channel for tracheal tube intubationDevice: KingVision , blade without channel for tracheal tube intubationDevice: A.P. Advance, blade without channel for tracheal tube intubationDevice: Macintosh
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 480
- Registration Number
- NCT02088801
- Locations
- 🇨🇭
Bern University Hospital and University of Bern, Bern, Switzerland
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
Not Applicable
Terminated
- Conditions
- Macular EdemaAge-related Macular DegenerationRetinal Vein OcclusionRetinal NeovascularizationCentral Serous Chorioretinopathy
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 18
- Registration Number
- NCT02088151
- Locations
- 🇨🇭
Department of Ophthalmology, Bern University Hospital, Bern, Switzerland
Ultrasound Assisted Puncture of AV Fistulas in Chronic Hemodialysis Patients
Not Applicable
Withdrawn
- Conditions
- FistulaDialysis
- Interventions
- Device: Ultrasound-assisted punctureOther: Standard
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Registration Number
- NCT02085486
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Phase 1
Terminated
- Conditions
- Gastroenteropancreatic Neuroendocrine Tumors
- Interventions
- Drug: Gallium-68-DOTATATE PET/CT (index test)Drug: Indium-111-Octreoscan (standard test)
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2016-09-07
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 54
- Registration Number
- NCT02078843
- Locations
- 🇨🇭
Nuclear Medicine, Bern University Hospital, Bern, Switzerland
Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Carbohydrate MetabolismType 1 Diabetes MellitusExerciseHypoglycemia
- Interventions
- Procedure: IHE first, CONT secondProcedure: GLU-FRU first, GLU secondProcedure: GLU first, GLU-FRU secondProcedure: CONT first, IHE second
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 27
- Registration Number
- NCT02068638
- Locations
- 🇨🇭
Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital, Bern, Switzerland
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 23
- Registration Number
- NCT02068625
- Locations
- 🇨🇭
Department of Ophthalmology, Bern University Hospital, Bern, Switzerland
Innate Human Collateral Supply to Different Vascular Regions
Completed
- Conditions
- AtherosclerosisCoronary Artery Disease
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 120
- Registration Number
- NCT02063347
- Locations
- 🇨🇭
Department of Cardiology, Bern University Hospital, Bern, Switzerland
Effects of Hemodynamic Monitoring Using the ImaCor Single Use Transesophageal Echocardiography Probe in Critically Ill Patients
Not Applicable
Completed
- Conditions
- Shock
- Interventions
- Device: ImaCor PMOther: Control SMDevice: ImaCor SMOther: Control PM
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 550
- Registration Number
- NCT02048566
- Locations
- 🇨🇭
Dep. of Intensive Care Medicine, Bern University Hospital, Bern, Switzerland
Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis
Phase 4
Completed
- Conditions
- Bacterial Vaginosis
- Interventions
- Device: Vaginal lactic acid and glycogen gel
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 32
- Registration Number
- NCT02042287
- Locations
- 🇨🇭
Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern, Berne, Switzerland
Acute Hemodynamic and Biological Effects of ECP and Exercise
Not Applicable
Completed
- Conditions
- Patients With Stable Coronary Artery Disease
- Interventions
- Other: Hemodynamic and biological measurements
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 20
- Registration Number
- NCT02014090
- Locations
- 🇨🇭
University Hospital, Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath